Protagonist Therapeutics, Inc.

Q3 2023 13F Holders

Symbol
PTGX
CUSIP
74366E102
Type
Equity
Class
COM
Num filings
151
Total reported value, excl. options
$947 M
Manager Report Date Value ($000) Shares Option Type